The Reason Silicon Valley Beat Out Boston for VC Dominance
Harvard Business Review
NOVEMBER 15, 2016
This post is one in a series of perspectives by presenters and participants in the 8th Global Drucker Forum. In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices.
Let's personalize your content